BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36123923)

  • 41. Rituximab in idiopathic membranous nephropathy.
    Ruggenenti P; Cravedi P; Chianca A; Perna A; Ruggiero B; Gaspari F; Rambaldi A; Marasà M; Remuzzi G
    J Am Soc Nephrol; 2012 Aug; 23(8):1416-25. PubMed ID: 22822077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Membranoproliferative glomerulonephritis associated with hypocomplementemic urticarial vasculitis after complete remission of membranous nephropathy.
    Saeki T; Ueno M; Shimada H; Nishi S; Imai N; Miyamura S; Gejou F; Arakawa M
    Nephron; 2001 Jun; 88(2):174-7. PubMed ID: 11399923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.
    Bobart SA; De Vriese AS; Pawar AS; Zand L; Sethi S; Giesen C; Lieske JC; Fervenza FC
    Kidney Int; 2019 Feb; 95(2):429-438. PubMed ID: 30665573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection.
    Wang R; Wu Y; Zheng B; Zhang X; An D; Guo N; Wang J; Guo Y; Tang L
    Sci Rep; 2021 Sep; 11(1):18407. PubMed ID: 34526634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Crescentic Glomerulonephritis With Immunoglobulin G4-Related Disease.
    Raber I; Ediriwickrema A; Higgins J; Kambham N; Pao AC
    Am J Med Sci; 2017 Sep; 354(3):236-239. PubMed ID: 28918828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case Report.
    Al-Rabadi L; Ayalon R; Bonegio RG; Ballard JE; Fujii AM; Henderson JM; Salant DJ; Beck LH
    Am J Kidney Dis; 2016 May; 67(5):775-8. PubMed ID: 26744127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of rituximab in patients with idiopathic membranous nephropathy: a case series and literature review.
    Jeon SJ; Kim JH; Noh HW; Lee GY; Lim JH; Jung HY; Cho JH; Choi JY; Kim CD; Kim YL; Park SH
    Korean J Intern Med; 2022 Jul; 37(4):830-840. PubMed ID: 35421909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Refractory Case of Secondary Membranous Nephropathy Concurrent with IgG4-related Tubulointerstitial Nephritis.
    Arai H; Toda N; Kamimatsuse R; Nishioka K; Endo S; Akiyama S; Maruyama S; Matsubara T; Yokoi H; Yanagita M
    Intern Med; 2018 Oct; 57(19):2873-2877. PubMed ID: 29709946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Membranous nephropathy: Diagnosis, new insights in pathophysiology, and therapeutic approach].
    Dahan K
    Rev Med Interne; 2016 Oct; 37(10):674-679. PubMed ID: 27236434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature.
    Roccatello D; Sciascia S; Di Simone D; Solfietti L; Naretto C; Fenoglio R; Baldovino S; Menegatti E
    Autoimmun Rev; 2016 Jun; 15(6):529-38. PubMed ID: 26876383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary membranous nephropathy with concomitant IgA nephropathy.
    Khorsan R; Hanna RM; Ameen K; Arman F; Nobakht N; Hasnain H; Hyunh A; Rastogi A
    Saudi J Kidney Dis Transpl; 2019; 30(2):531-536. PubMed ID: 31031392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A
    Tominaga K; Uchida T; Imakiire T; Itoh K; Shimazaki H; Nakanishi K; Kumagai H; Oshima N
    BMC Nephrol; 2018 May; 19(1):120. PubMed ID: 29792176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Update membranous nephropathy].
    Hoxha E; Huber TB
    Dtsch Med Wochenschr; 2020 Oct; 145(20):1481-1485. PubMed ID: 33022730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
    Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
    J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
    Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ofatumumab for multirelapsing membranous nephropathy complicated by rituximab-induced serum-sickness.
    Podestà MA; Ruggiero B; Remuzzi G; Ruggenenti P
    BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31980477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of rituximab therapy for membranous nephropathy: a meta-analysis.
    Zhang J; Bian L; Ma FZ; Jia Y; Lin P
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):8021-8029. PubMed ID: 30536351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
    Fervenza FC; Canetta PA; Barbour SJ; Lafayette RA; Rovin BH; Aslam N; Hladunewich MA; Irazabal MV; Sethi S; Gipson DS; Reich HN; Brenchley P; Kretzler M; Radhakrishnan J; Hebert LA; Gipson PE; Thomas LF; McCarthy ET; Appel GB; Jefferson JA; Eirin A; Lieske JC; Hogan MC; Greene EL; Dillon JJ; Leung N; Sedor JR; Rizk DV; Blumenthal SS; Lasic LB; Juncos LA; Green DF; Simon J; Sussman AN; Philibert D; Cattran DC;
    Nephron; 2015; 130(3):159-68. PubMed ID: 26087670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Membranous glomerulonephritis with crescent overlapping].
    Li Cavoli G; Passantino R; Ferrantelli A; Bono L; Tortorici C; Giammarresi C; Li Cavoli TV; Ferrantelli G; Rotolo U
    G Ital Nefrol; 2015; 32(6):. PubMed ID: 26845212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary membranous nephropathy in children and adolescents: a single-centre report from South Asia.
    Ramachandran R; Nayak S; Kumar V; Kumar A; Agrawal N; Bansal R; Tiewsoh K; Nada R; Rathi M; Kohli HS
    Pediatr Nephrol; 2021 May; 36(5):1217-1226. PubMed ID: 33108509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.